Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Bortezomib |
gCSI, CTRPv2 | bortezomib |
PharmacoGx | Bortezomib |
Database | Identifier |
---|---|
Smiles: | B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O |
Inchikey: | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Pubchem: | 387447 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAD51C | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
mRNA | JAK2 | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
mRNA | RFX7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | FUCA1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
mRNA | SNX1 | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
mRNA | UVSSA | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
mRNA | SLC12A1 | FIMM | pan-cancer | AAC | -0.38 | 0.005 |
mRNA | GNL1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | PRH1-PRR4 | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
mRNA | C17orf98 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |